TRIDEM PHARMA
TRIDEM PHARMA, a prominent player in the pharmaceutical industry, is headquartered in France and operates extensively across Europe and beyond. Founded in 2000, the company has established itself as a leader in the development and distribution of innovative healthcare solutions, particularly in the fields of dermatology and pain management. With a diverse portfolio of unique products, TRIDEM PHARMA focuses on delivering high-quality pharmaceuticals that meet the evolving needs of patients and healthcare professionals. The company is recognised for its commitment to research and development, which has led to several key milestones in product innovation and market expansion. TRIDEM PHARMA's strategic position in the market is underscored by its dedication to excellence and a strong reputation for reliability, making it a trusted partner in the healthcare sector.
DitchCarbon Score
How does TRIDEM PHARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TRIDEM PHARMA's score of 6 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
TRIDEM PHARMA's reported carbon emissions
TRIDEM PHARMA, headquartered in France, currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. As the sector increasingly focuses on sustainability, TRIDEM PHARMA's future climate commitments and strategies will be essential for understanding its role in reducing greenhouse gas emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
TRIDEM PHARMA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
